Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

QAS DTPS > DTPS > Flashcards

DTPS Flashcards

1
Q

Adrenaline Indications

A
  • Anaphylaxis OR severe allergic reaction
  • Severe life-t)hreatening bronchospasm OR silent chest (patient must be only able to speak in single words AND/OR have haemodynamic compromise AND/OR an ALOC
  • Bradycardia with poor perfusion (unresponsive to atropine AND/OR TCP
  • Cardiac arrest - Croup (with stridor at rest)
  • Shock unresponsive to adequate fluid resuscitation (excluding haemorrhagic cause)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Adrenaline Contraindications

A

Nil

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Adrenaline Precautions

A
  • Hypertension
  • Hypovolaemic shock
  • Concurrent MAOI therapy
  • Multiple sclerosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Adrenaline Side effects

A
  • Anxiety
  • Hypertension
  • Palpitations/tachyarrhythmias
  • Pupil Dilation
  • Tremor
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Adrenaline Onset

A

IV - 30 seconds

IM - 60 seconds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Adrenaline Duration

A

5-10 minutes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Adrenaline Half-life

A

2 minutes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Adrenaline Adult Dosage

Anaphylaxis OR severe allergic reaction

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Adrenaline

Adult Dosage

Severe Life Threatening Bronchospasm OR Silent Chest

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Adrenaline

Adult Dosage

Bradycardia with poor perfusion (Unresponsive to Atropine AND/OT TCP)

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Adrenaline

Adult Dosage

Cardiac Arrest

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Adrenaline

Adult Dosage

Shock unresponsive to adequate fluid resuscitation (excluding haemorrhagic cause)

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Amiodarone Indications

A

Cardiac Arrest (Refractory VF or pulseless VT)

Sustained conscious VT (haemodynamically stable)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Amiodarone Contraindications

A
  • Cardiac Arrest (Refractory VF or pulseless VT)
  • Nil
  • Sustained Conscious VT (haemodynamically stable)
  • KSAR or hypersensitivity
  • severe conduction disorders (unless pacemaker or AICD in situ)
  • Current amiodarone therapy
  • Current anti-arrhythmic therapy that prolonges QT interval
  • Pregnancy and/or lactation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Amiodarone Precautions

A

Cardiac arrest

  • concurrent anti-arrhythmic therapy that prolongs QT interval
  • thyroid disease

Sustained conscious VT

  • hypotension
  • thyroid disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Amiodarone Side Effects

A

Hypotension

Bradycardia

Nausea and/or vomitting

Peripheral paresthesia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Amiodarone Onset

A

5 minutes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Amiodarone Duration

A

30 minutes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Amiodarone Half-Life

A

14-110 days (with chronic dosing)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Amiodarone Schedule

A

S4 (Restricted drugs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Amiodarone Adult Dosages

Cardiac Arrest

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Amiodarone Adult Dosages

Sustainded conscious VT

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Aspirin Indications

A

Suspected ACS

Acute cardiogenic Pulmonary Oedema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Aspiring Contraindications

A

KSAR or hypersensitivity to aspirin or other NSAIDs

Chest pain associated with psychostimulant overdose

Bleeding OR clotting disorder

Current GI bleed or peptic ulcers

Patients <18 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Aspirin Precautions

A

Possible aortic aneurysm, or other condition that may require surgery

Pregnancy

History of GI bleeds or peptic ulcers

Current anticoagulant therapy (e.g. warfarin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Aspirin Side Effects

A

Epigastric pain / discomfort

Nausea and/or vomiting

Gastritis

GI bleed

NSAID induced bronchospasm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Aspirin Onset

A

approx. 10 minutes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Aspirin Duration

A

approx. 1 week

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Aspirin Schedule

A

S2 (therapeutic poisons)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Aspirin Adult Dosage

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Atropine Indications

A

Bradycarda (with poor perfusion)

Envenomation (with increased parasympathetic activity)

Hypersalivation (secondary to ketamine administration)

Organophosphate toxicity (with cardiac AND/OR respiratory compromise

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Atropine Contraindications

A

KSAR or hypersensitivity to atropine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Atropine precautions

A

Atrial flutter

Atrial fibrillation

AMI

Glaucoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Atropine Side Effects

A

Agitation

Hallucinations

Dilated Pupils

Dry mouth/ dry skin/ reduced bronchial and gastric secretion

Tachycardia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Atropine Onset

A

1-2 minutes

(peak 15-50 minutes)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Atropine Duration

A

Up to 5 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Atropine Schedule

A

S4 (restricted drugs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Atropine Adult Dosages

Bradycardia

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Atropine Adult Dosages

Envenomation

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Atropine Adult Dosages

Hypersalivation

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Atropine Adult Dosages

Organophosphate toxicity

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Ceftriaxone Indications

A

Suspected meningococcal septicaemia (with a non-blanching petchial AND/OR purpuric rash)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Ceftriaxone Contraindication

A

KSAR or Hypersensitivity to cephalosporin drugs

Known anaphylaxis or severe allergice reaction fo penicillin based drugs - (isolated minor drug rash attributed to penicillin does not contraindicate the use of ceftriaxone)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Ceftriaxone Precuation

A

Nil

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Ceftriaxone Side effects

A

Nausea AND/OR vomiting

Pain at the IM administration site

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

Ceftriaxone Presentation

A

Vial (powder), 1g ceftriaxone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

Ceftriaxone Onset

Duration

Half Life

A

Dose/route variable

Duration: approx. 1 day

Half Life: 5.8-8.7 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

Ceftriaxone Schedule

A

S4 (restricted drugs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

Ceftriaxone Adult Dose

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

Fentalyn Indications

A
  • Severe Pain
  • Sedation (for maintenance of an established ETT)
  • Autonomic dysreflexia (with significant BP 160 mmHg)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

Fentanyl Contraindications

A

KSAR or hypersensitivity to fentanyl

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

Fentanyl Precautions

A
  • Respiratory Tract burns
  • Respiratory depression and/or failure
  • Known addiction to narcotics
  • Current MAOI therapy
  • Elderly patients
  • Hypotension
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

Fentanyl Side Effects

A
  • Bradycardia
  • Hypotension
  • Drowsiness
  • Nausea and/or vomiting
  • pin point pupils
  • Respiratory depression
  • Muscular rigidity (particularly muscles of respiration.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

Fentanyl Onset/Duration/Half Life

A

Onset: <3 minutes

Duration: 30-60 minutes

Half Life: 2-3 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

Fentanyl Schedule

A

S8 (controlled drug)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

Fentanyl Adult Dosage

Severe Pain

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
57
Q

Fentanyl Adult Dosage

Severe Pain

Autonomic dysreflexia (Severe Hypertension BP 160 Hgmm)

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
58
Q

Fentanyl Adult Dosage

Sedation (for maintenance of existing ETT)

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
59
Q

Glucagon Indications

A

Symptomatic hypoglycaemia (with inability to self administer oral glucose)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
60
Q

Glucagon Contraindications

A

KSAR of hypersensitivity to glucagon

61
Q

Glucagon Precautions

62
Q

Glucagon side effects

63
Q

Glucagon Onset/Duration/Half Life

A

Onset: 4-7 minutes

Duration: Variable

Half-Life: 3-6 minutes

64
Q

Glucagon Schedule

A

S3 (therapeutic poison)

65
Q

Glucagon Adult Dosage

66
Q

Glyceryl trinitrate Indications

A

Suspected ACS with Pain

Acute cardiogenic pulmonary oedema

Irukandji syndrome (with systolic BP greater than or equal to 160 mmHg)

Autonomic dysreflexia (with systolic BP greater than or equal to 160 mmHg)

67
Q

GTN contraindications

A

KSAR or hypersensitivity to GTB

HR < 50 or >150

SBP <100

Acute CVA

Head trauma

Phosphodiesterase Inhibitor medication administration in previous 24 hours

68
Q

GTN Precautions

A

Phosphodiesterase inhibitor medication administration in previous 48 hours

Suspected inferior AMI

Cerebral vascular disease

Risk of hypotension or syncope

Intoxication (GTN effects enhances)

69
Q

GTN side effects

A

Dizziness

Syncope

Hypotension

Reflex tachycardia

Vascular headaches

70
Q

GTN Onset/Duration/Half-Life

A

Onset: <2 minutes

Duration: 20-30 minutes

Half-Life: 5.5 minutes

71
Q

GTN Schedule

A

Sublingual: S3 (therapeutic poisons)

Ampoule: S4 (restricted drugs)

72
Q

GTN Dosages

73
Q

Hydrocortisone Indications

A
  • Moderate or Severe Asthma
  • Acute exacerbation of COPD (with evidence of respiratory distress)
  • Severe allergic reaction OR anaphylaxis (requiring adrenaline administration)
  • Symptomatic adrenal insuficiency (with a known history of Adison’s disease, congenital adrenal hyperplasia, pan-hypopertuitarism or long-term steroid administration)
74
Q

Hydrocortisone Contraindications

A

KSAR or hypersensitivity to hydrocortisone

75
Q

Hydrocortisone Precautions

A

Hypertesion

76
Q

Hydrocortisone Side effects

77
Q

Hydrocortisone Onset/Duration/Side Effects

A

Onset: 1-2 hours

Duration: 6-12 hours

Half life: 6-8 hours

78
Q

Hydrocortisone Schedule

A

S4 (restricted drugs)

79
Q

Hydrocortisone Dosages

80
Q

Ipratropium Bromide Indications

A

Moderate or Severe Bronchospasm

81
Q

Ipratropium Bromide Contraindications

A

KSAR or hypersensitivity

Patient <2 yrs

82
Q

Ipratropium bromide Precautions

83
Q

Ipratropium Bromide Side Effects

A

Dilated pupils

Dry mouth

Plpitations

84
Q

Ipratropium Bromide Onset/Duration/Half-life

A

Onset: 1.5-3 minutes

Duration: 4-6 hours

Half-Life: 3 hours

85
Q

Ipratropium bromide Schedule

86
Q

Ipratropium Bromide Adult Dosages

87
Q

Ketamine Indications

A
  • Severe traumatic Pain (following 0.1-0.2 mg/kg of morphine OR 1-2 mcg/kg fentanyl) associated iwth:
    • Fracture reduction and splinting
    • Multiple significant fractures requiring facilitated extrication
    • patients with splinted fractures requiring ongoing narcotic analgesia for transport requirements
  • Severe traumatic pain associated with burns (following 0.2-0.3 mg/kg morphine OR 2-3 mcg/kg fentanyl AND 1-2 mg (adult or 0.05mcg/kg (paediatric) midazolam)
  • Induction of anaeshtesia
  • Ongoing traumatic pain unresponsiv eto narcotics (following 0.2-0.3 mg/kg morphine OR 2-3 mcg/kg Fentanyl)
88
Q

Ketamine Contraindications

Analgesia

A
  • KSAR or hypersensitivity
  • Age <1 yr
  • GCS 12 or less
  • Uncontrolled hypertension (SBP 180mmHg or less AND/OR DBP 110 mmHg or less)
  • Suspected acute ACS or acute heart failure
  • Known Hydrocephalus or raised intraocular pressure
89
Q

Ketamine Contraindications

Induction of anaethsesia

A

KSAR or Hypersensitivity

90
Q

Ketamine Precautions

A
  • Age >65
  • Patients hwo have been administered midaolam or other CNS depressant medications
  • Patients with significant hypovolaemia (exaggerated effects and a delayed onset of action)
  • Globe injuries
  • Complex facial injuries and fractures
  • Patients who have imparied respiratory function
  • Patients exhibiting psychotic symptoms
91
Q

Ketamine Side Effects

A
  • Dissociation and trance-like state
  • transient hypertonicity and nystagmus
  • disinhibition
  • emergence
  • hypertension
  • tachycardia
  • depression of consciousness
  • hypersalivation
  • nausea and/or vomiting
  • laryngospam
  • respiratory depression (rare)
92
Q

Ketamine Onset/Duration/Half Life

Schedule

A

Onset: 30 seconds

Duration 5-20 minutes

Half Life: 10-15 minutes

Schedule: S8 (controleld drugs)

93
Q

Ketamine Adult Dosages

Severe Traumatic Pain

94
Q

Ketamine Adult Dosage

Severe traumatic pain associated with burns

95
Q

Ketamine Adult Dosages

Induction for Anaesthesia

96
Q

Lignocaine Indications

A
  • Pain associated with IO drug and fluid administration following EZ-IO needle insertion
  • Local anaesthesia
    • radial artery line placeent
    • fish hook removal
97
Q

Lignocaine Contraindications

A

KSAR or hypersensitivity to Lignocaine

98
Q

Lignocaine Precautions

A

Inadvertent intravascular injection

99
Q

Lignocaine Side effects

A

Convulsions

Hypotension

Nausea

Tinnitus

100
Q

Lignocaine Onset/Duration/Half Life

Schedule

A

Onset: 1-3 minutes

Duration: 20-30 minutes

Half life: 1-2 hours

Schedule: S4 (Restricted drugs)

101
Q

Lignocaine Dosages

102
Q

Magnesium Sulphate Indications

A
  • Box jellyfish (Chironex fleckeri) evenomation (unresponsive to antivenom threapy)
  • Eclampsia
  • Irukandji sydrome (with intractable pain unreleived by narcotic analgesia AND/OR systolic BP > 160 mmHg)
  • Torsades de Pointes
  • Severe life-threatening asthma (only in patients who have required IV salbutamol AND/OR IM/IV adrenaline)
103
Q

Magnesium Sulphate conraindications

A
  • KSAR or hypersensitivity to magnesium sulphate
  • AV block
  • Renal failure
104
Q

Magnesium Sulphate Precautions

A

Renal impairment

105
Q

Magnesium Sulphate Side Effects

A
  • Pain at cannulation site
  • Magnesium toxicity
    • hypotension/respiratory depression
    • loss of deep tendon reflexes
106
Q

Magnesium Sulphate Onset/Duration/Half Life

Schedule

A

Onset: immediate

Duration: 30 minutes

Half-life: variable

Schedule: unscheduled

107
Q

Magnesium Sulphate Adult Dosages

Torsades do pointes

108
Q

Magnesium Sulphate Adult Dosage

Box Jellyfish

109
Q

Magnesium Sulphate Adult Dosage

Irukandji Syndrome

110
Q

Magnesium Sulphate Adult Dosage

Eclampsia

111
Q

Methoxyfleurane Indications

112
Q

Methoxyfleurane Contraindications

A
  • KSAR or hypersensitivity
  • Patient <1 yr
  • History of significat liver or renal disease
  • History of malignant hyperthermia
113
Q

Methoxyfleurane Precautions

A

ALOC

Intoxicated or drug affected patients

114
Q

Methoxyfleurane side effects

A

ALOC

Cough

Renal/hepatic failure (following repeated high dose exposure)

115
Q

Methoxyfleurane Onset/Duration/Half-Lfe

Schedule

A

Onset: 1-3 minutes

Duration: 5-10 minutes

Half-life: not available

Schedule: S4 restricted drugs

116
Q

Methoxyfleurane Adult Dosage

117
Q

Morphine Indications

A
  • Significiant pain
  • Autonomic dysreflexia (with systolic BP >160mmHg)
  • Sedation for the maintenance of an established ETT
118
Q

Morphine Contraindications

A

KSAR or hypersensitivity to morphine

Renal failure

119
Q

Morphine Precautions

A
  • Elderpy patient
  • hypotension
  • respiratory tract burns
  • respiratory depression and/or failure
  • known addiction to narcotics
  • concurrent MAOI therapy
  • Cardiac chest pain
120
Q

Morphine Side effects

A
  • Hypotension
  • Drowsiness
  • Nausea/vomiting
  • Bradycardia
  • Pin point pupils
  • Respiratory depression
121
Q

Morphine Onset/Duration/Half-life

Schedule

A

Onset: (IM) 5-10 minutes (peak 20-30 minutes)

(IV) 2-5 minutes (peak 20 minutes)

Duration: 1-2 hours

Half-life: 2 hours

Schedule: S8 controlled drugs

122
Q

Morphine Adult Dosages

Significant Pain (ACP1)

123
Q

Morphine Adult Dosage

Significant Pain

Autonomic Dysreflexia

124
Q

Morphine Adult Dosages

Sedation

125
Q

Naloxone Indications

A

Respiratory depression (secondary to administration of narcotic drugs)

126
Q

Naloxone Contraindications

A

KSAR or hypersensitivity to naloxone

127
Q

Naloxone Precautions

A

Use with caution on patients with preexisting cardiac disease

128
Q

Naloxone side effects

A
  • Narcotic reversal can cause combativeness, vomiting, sweating, tachycardia and hypertension
  • May produce acute withdrawal convulsions in the chronic narcotic user
  • Pulmonary oedema
129
Q

Naloxone Onset/Duration/Half-life

Schedule

A

Onset: 3-5 min (IM)/1-3 min (IV)

Duration; approx. 60 min

Half-life: 60 min

Schedule: 24 (restricted drugs

130
Q

Naloxone Adult Dosage

131
Q

Ondansetron Indications

A

Nausea and/or vomiting

Prophylactic administration for patients presenting with ACS

132
Q

Ondansetron contraindications

A
  • KSAR to ondansetron or other 50HY3 receptor antagonists
  • Congenital long QT syndrome
  • Patient <3 years
133
Q

Ondansetron precautions

A

Hepatic impairment

Intestinal obstruction

Patients with risk factors for QT interval prologation or cardiac arrythmias

134
Q

Ondansetron Side Effects

A

Headache

Constipation

Sensation of warmth or flushing

Dysrhythmias

135
Q

Ondansetron Onset/Duration/Half-life

A

Onset: 5 minutes

Duration: several hours

Half-life: 3-4 hours

Schedule: S4 (restricted drugs)

136
Q

Ondansetron Adult Dosages

137
Q

Paracetamol Indications

A

Minor pain

Fever (causing distress)

138
Q

Paracetamol Contraindications

A

KSAR of hypersensiticity to paracetamol

Patient < 1 month old

139
Q

Paracetamol side effects

140
Q

Paracetamol Onset/Duration/Half Life

Schedule

A

Onset: 10-60 minutes

Duration: 4 hours

Half-life: approx. 2 hours

Schedule S2 (therapeutic poison)

141
Q

Paracetamol Adullt Dosage

142
Q

Salbutamol Indications

A

Bronchospasm

Suspected hyperkalaemia (with QRS widening AND/OR AV dissociation

143
Q

Paracetamol Contraindications

A

KSAR or hypersensitivity to salbutamol

Patient < 2 years

144
Q

Salbutamol Precautions

A

Acute Pulmonary oedema

Ischaemic heart disease

145
Q

Salbutamol Side effects

A

Anxiety

Tachyarrythmia

Tremors

Hypokalaemia and metabolic acidosis

146
Q

Salbutamol Onset/Duration/Half Life

A

Onset: 2-5 minutes (NEB)/1-3 minutes (IV)

Duration: 16-60 minutes (NEB)/10-20 minutes (IV

Half Life: 1.6 hours

147
Q

Salbutamol adult dosages

Bronchospasm

148
Q

Salbutamol adult dosages

Suspected hyperkalaemia

QAS DTPS (3 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions